BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24565897)

  • 1. Carboxyl-terminal multi-site phosphorylation regulates internalization and desensitization of the human sst2 somatostatin receptor.
    Lehmann A; Kliewer A; Schütz D; Nagel F; Stumm R; Schulz S
    Mol Cell Endocrinol; 2014 Apr; 387(1-2):44-51. PubMed ID: 24565897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural determinants of agonist-selective signaling at the sst(2A) somatostatin receptor.
    Nagel F; Doll C; Pöll F; Kliewer A; Schröder H; Schulz S
    Mol Endocrinol; 2011 May; 25(5):859-66. PubMed ID: 21330405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro.
    Lesche S; Lehmann D; Nagel F; Schmid HA; Schulz S
    J Clin Endocrinol Metab; 2009 Feb; 94(2):654-61. PubMed ID: 19001514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pasireotide and octreotide stimulate distinct patterns of sst2A somatostatin receptor phosphorylation.
    Pöll F; Lehmann D; Illing S; Ginj M; Jacobs S; Lupp A; Stumm R; Schulz S
    Mol Endocrinol; 2010 Feb; 24(2):436-46. PubMed ID: 20051480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor cultures.
    Mohamed A; Blanchard MP; Albertelli M; Barbieri F; Brue T; Niccoli P; Delpero JR; Monges G; Garcia S; Ferone D; Florio T; Enjalbert A; Moutardier V; Schonbrunn A; Gerard C; Barlier A; Saveanu A
    Endocr Relat Cancer; 2014 Oct; 21(5):691-704. PubMed ID: 25012983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-dependent mechanisms of sst2A receptor trafficking: role of site-specific phosphorylation and receptor activation in the actions of biased somatostatin agonists.
    Kao YJ; Ghosh M; Schonbrunn A
    Mol Endocrinol; 2011 Jun; 25(6):1040-54. PubMed ID: 21493671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of threonine 333 regulates trafficking of the human sst5 somatostatin receptor.
    Petrich A; Mann A; Kliewer A; Nagel F; Strigli A; Märtens JC; Pöll F; Schulz S
    Mol Endocrinol; 2013 Apr; 27(4):671-82. PubMed ID: 23418396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct phosphorylation sites in the SST2A somatostatin receptor control internalization, desensitization, and arrestin binding.
    Liu Q; Dewi DA; Liu W; Bee MS; Schonbrunn A
    Mol Pharmacol; 2008 Feb; 73(2):292-304. PubMed ID: 17981995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The third intracellular loop of the human somatostatin receptor 5 is crucial for arrestin binding and receptor internalization after somatostatin stimulation.
    Peverelli E; Mantovani G; Calebiro D; Doni A; Bondioni S; Lania A; Beck-Peccoz P; Spada A
    Mol Endocrinol; 2008 Mar; 22(3):676-88. PubMed ID: 18096696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porcine somatostatin receptor 2 displays typical pharmacological sst2 features but unique dynamics of homodimerization and internalization.
    Durán-Prado M; Bucharles C; Gonzalez BJ; Vázquez-Martínez R; Martínez-Fuentes AJ; García-Navarro S; Rhodes SJ; Vaudry H; Malagón MM; Castaño JP
    Endocrinology; 2007 Jan; 148(1):411-21. PubMed ID: 17053026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of beta-Arrestin 1 with the type 1A angiotensin II receptor involves phosphorylation of the receptor carboxyl terminus and correlates with receptor internalization.
    Qian H; Pipolo L; Thomas WG
    Mol Endocrinol; 2001 Oct; 15(10):1706-19. PubMed ID: 11579203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serine residues 338 and 339 in the carboxyl-terminal tail of the type II gonadotropin-releasing hormone receptor are critical for beta-arrestin-independent internalization.
    Ronacher K; Matsiliza N; Nkwanyana N; Pawson AJ; Adam T; Flanagan CA; Millar RP; Katz AA
    Endocrinology; 2004 Oct; 145(10):4480-8. PubMed ID: 15205374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Octreotide and pasireotide (dis)similarly inhibit pituitary tumor cells in vitro.
    Ibáñez-Costa A; Rivero-Cortés E; Vázquez-Borrego MC; Gahete MD; Jiménez-Reina L; Venegas-Moreno E; de la Riva A; Arráez MÁ; González-Molero I; Schmid HA; Maraver-Selfa S; Gavilán-Villarejo I; García-Arnés JA; Japón MA; Soto-Moreno A; Gálvez MA; Luque RM; Castaño JP
    J Endocrinol; 2016 Nov; 231(2):135-145. PubMed ID: 27587848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Phosphorylation Sites Regulating sst3 Somatostatin Receptor Trafficking.
    Lehmann A; Kliewer A; Günther T; Nagel F; Schulz S
    Mol Endocrinol; 2016 Jun; 30(6):645-59. PubMed ID: 27101376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transplantable phosphorylation probe for direct assessment of G protein-coupled receptor activation.
    Kliewer A; Mann A; Petrich A; Pöll F; Schulz S
    PLoS One; 2012; 7(6):e39458. PubMed ID: 22745760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Internalization of sst2, sst3, and sst5 receptors: effects of somatostatin agonists and antagonists.
    Cescato R; Schulz S; Waser B; Eltschinger V; Rivier JE; Wester HJ; Culler M; Ginj M; Liu Q; Schonbrunn A; Reubi JC
    J Nucl Med; 2006 Mar; 47(3):502-11. PubMed ID: 16513620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor signaling and endocytosis are differentially regulated by somatostatin analogs.
    Liu Q; Cescato R; Dewi DA; Rivier J; Reubi JC; Schonbrunn A
    Mol Pharmacol; 2005 Jul; 68(1):90-101. PubMed ID: 15855408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of somatostatin SST(2) receptor internalization in vivo after intravenous SOM230 application in the AR42J animal tumor model.
    Waser B; Cescato R; Tamma ML; Maecke HR; Reubi JC
    Eur J Pharmacol; 2010 Oct; 644(1-3):257-62. PubMed ID: 20643121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homologous and heterologous regulation of somatostatin receptor 2.
    Elberg G; Hipkin RW; Schonbrunn A
    Mol Endocrinol; 2002 Nov; 16(11):2502-14. PubMed ID: 12403839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a Ser/Thr cluster in the C-terminal domain of the human prostaglandin receptor EP4 that is essential for agonist-induced beta-arrestin1 recruitment but differs from the apparent principal phosphorylation site.
    Neuschäfer-Rube F; Hermosilla R; Rehwald M; Rönnstrand L; Schülein R; Wernstedt C; Püschel GP
    Biochem J; 2004 May; 379(Pt 3):573-85. PubMed ID: 14709160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.